Zhu XM, et al. - Researchers performed this meta-analysis of randomized, double-blind, placebo-controlled trials (RCTs) to evaluate the efficacy and safety of adjunctive raloxifene for postmenopausal women with schizophrenia. As per findings, adjunctive raloxifene appeared to be effective and safe in improving psychotic symptoms for these women.